BE1027772B1 - Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique - Google Patents

Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique

Info

Publication number
BE1027772B1
BE1027772B1 BE20195810A BE201905810A BE1027772B1 BE 1027772 B1 BE1027772 B1 BE 1027772B1 BE 20195810 A BE20195810 A BE 20195810A BE 201905810 A BE201905810 A BE 201905810A BE 1027772 B1 BE1027772 B1 BE 1027772B1
Authority
BE
Belgium
Prior art keywords
composition
ginseng
treatment
skin condition
improve skin
Prior art date
Application number
BE20195810A
Other languages
English (en)
Other versions
BE1027772A1 (fr
Inventor
Sylvie Defrere
Pierre-Antoine Mariage
Original Assignee
Botalys Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Botalys Sa filed Critical Botalys Sa
Priority to BE20195810A priority Critical patent/BE1027772B1/fr
Priority to US17/753,391 priority patent/US20220288147A1/en
Priority to EP20771997.2A priority patent/EP4025231B1/fr
Priority to JP2022513665A priority patent/JP2022553120A/ja
Priority to PCT/EP2020/074649 priority patent/WO2021043927A1/fr
Priority to AU2020342706A priority patent/AU2020342706A1/en
Publication of BE1027772A1 publication Critical patent/BE1027772A1/fr
Application granted granted Critical
Publication of BE1027772B1 publication Critical patent/BE1027772B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur une composition, un kit et sa préparation pour améliorer l'état de la peau d'un sujet. L'invention concerne également la composition destinée à être utilisée comme substance médicale ou thérapeutique. La composition comprend un ginsénoside rare, un ginsan et un gintonin. De préférence, le rapport entre le ginsan et la gintonine est d'au moins 500:1 et d'au plus 1:100. De préférence, le rapport des ginsénosides rares au ginsan et à la gintonine est d'au moins 250:1 et d'au plus 1:40.
BE20195810A 2019-09-03 2019-11-21 Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique BE1027772B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BE20195810A BE1027772B1 (fr) 2019-11-21 2019-11-21 Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique
US17/753,391 US20220288147A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament
EP20771997.2A EP4025231B1 (fr) 2019-09-03 2020-09-03 Composition de ginseng et son utilisation en tant que médicament
JP2022513665A JP2022553120A (ja) 2019-09-03 2020-09-03 ニンジン組成物及び医薬としてのその使用
PCT/EP2020/074649 WO2021043927A1 (fr) 2019-09-03 2020-09-03 Composition de ginseng et son utilisation en tant que médicament
AU2020342706A AU2020342706A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20195810A BE1027772B1 (fr) 2019-11-21 2019-11-21 Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique

Publications (2)

Publication Number Publication Date
BE1027772A1 BE1027772A1 (fr) 2021-06-15
BE1027772B1 true BE1027772B1 (fr) 2021-06-21

Family

ID=69571743

Family Applications (1)

Application Number Title Priority Date Filing Date
BE20195810A BE1027772B1 (fr) 2019-09-03 2019-11-21 Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique

Country Status (1)

Country Link
BE (1) BE1027772B1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663160A (en) * 1992-09-17 1997-09-02 Lvmh Recherche Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair
FR2767057A1 (fr) * 1997-08-08 1999-02-12 Lvmh Rech Utilisation du ginsenoside rb1 comme agent destine a stimuler la synthese de l'elastine
WO2013176512A1 (fr) * 2012-05-25 2013-11-28 Korea Institute Of Science And Technology Extrait de ginseng (panax spp.) ayant une teneur accrue en ginsénosides rg3, rg5 et rk1 produits par irradiation par micro-ondes, procédé de préparation de l'extrait de ginseng (panax spp.) et composition comprenant l'extrait de ginseng (panax spp.)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574806A (en) 1976-06-03 1980-09-10 Inverni Della Beffa Spa Production of purified ginseng extracts and pharmaceutical compositions containing the extracts
US4966893A (en) 1989-01-13 1990-10-30 Pang Peter K T Method for treatment of senile dementia
JPH04316448A (ja) 1991-04-12 1992-11-06 Iwatani Internatl Corp 人参微粉末の製造方法
US6083932A (en) 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
KR20010023208A (ko) 1997-08-28 2001-03-26 브루스, 제임스 에이취 허브 추출물의 화학 및 약리학적 표준화
KR20020035855A (ko) 1999-08-30 2002-05-15 마쯔오 미쯔요시 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
JP2002249498A (ja) 2001-02-21 2002-09-06 Japan Science & Technology Corp ジンセノサイド類誘導体からなる抗アポトーシス剤又は再生促進剤
JP2002255826A (ja) 2001-02-27 2002-09-11 Japan Science & Technology Corp 角膜組織再生促進剤
JP2003070496A (ja) 2001-09-03 2003-03-11 Shin Sangyo Gijutsu Kenkyusho:Kk 薬理活性サポニンの評価方法および薬理活性サポニン
JP2004077456A (ja) 2002-06-18 2004-03-11 Masahiro Sakanaka ジンセノサイドＲｂ１様物質のスクリーニング方法
KR100521505B1 (ko) 2003-05-14 2005-10-12 주식회사 바이오사포젠 진세노사이드 Rh2 및 진세노사이드 Rg3를 함유함을 특징으로 하는 자외선 차단용 화장료 조성물
JP2006028150A (ja) 2004-07-20 2006-02-02 Fumiyuki Terada 皮膚弾力性賦活化粧料
KR100973202B1 (ko) 2009-11-17 2010-07-30 건국대학교 산학협력단 인삼에서 분리 동정한 신규한 당지질단백질 및 그 제조방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663160A (en) * 1992-09-17 1997-09-02 Lvmh Recherche Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair
FR2767057A1 (fr) * 1997-08-08 1999-02-12 Lvmh Rech Utilisation du ginsenoside rb1 comme agent destine a stimuler la synthese de l'elastine
WO2013176512A1 (fr) * 2012-05-25 2013-11-28 Korea Institute Of Science And Technology Extrait de ginseng (panax spp.) ayant une teneur accrue en ginsénosides rg3, rg5 et rk1 produits par irradiation par micro-ondes, procédé de préparation de l'extrait de ginseng (panax spp.) et composition comprenant l'extrait de ginseng (panax spp.)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Ginseng HRG80 in Stress and Fatigue - Full Text View - ClinicalTrials.gov", 13 May 2019 (2019-05-13), XP055692252, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/NCT03947554> [retrieved on 20200506] *
HWANG JI EUN ET AL: "Comparative study on anti-oxidative and anti-inflammatory properties of hydroponic ginseng and soil-cultured ginseng", FOOD SCIENCE AND BIOTECHNOLOGY, THE KOREA SOC. OF FOOD SCIENCE AND TECHNOLOGY, HEIDELBERG, vol. 28, no. 1, 30 August 2018 (2018-08-30), pages 215 - 224, XP036980989, ISSN: 1226-7708, [retrieved on 20180830], DOI: 10.1007/S10068-018-0450-X *
PIERRE-ANTOINE MARIAGE ET AL: "Efficacy of Panax ginseng Meyer Herbal Preparation HRG80 in Preventing and Mitigating Stress-Induced Failure of Cognitive Functions in Healthy Subjects: A Pilot, Randomized, Double-Blind, Placebo-Controlled Crossover Trial", PHARMACEUTICALS, vol. 13, no. 4, 29 March 2020 (2020-03-29), CH, pages 57, XP055691690, ISSN: 1424-8247, DOI: 10.3390/ph13040057 *
PIERRE-ANTOINE MARIAGE: "Ginseng HRG80 : un nouvel ingrédient naturel à l'efficacité renforcée", 13 November 2018 (2018-11-13), XP055692164, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/ginseng-hrg80-un-nouvel-ingredient-naturel-a-l-efficacite-renforcee> [retrieved on 20200506] *
PIERRE-ANTOINE MARIAGE: "Ginseng HRG80 : un nouvel ingrédient naturel à l'efficacité renforcée", 22 November 2018 (2018-11-22), XP055692168, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/ginseng-hrg80-un-nouvel-ingredient-naturel-a-l-efficacite-renforcee> [retrieved on 20200506] *
PIERRE-ANTOINE MARIAGE: "Pourquoi opter pour le ginseng HRG80 dans vos produits nutraceutiques ?", 20 November 2018 (2018-11-20), XP055692170, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/pourquoi-opter-pour-le-ginseng-hrg80-dans-vos-produits-nutraceutiques> [retrieved on 20200506] *

Also Published As

Publication number Publication date
BE1027772A1 (fr) 2021-06-15

Similar Documents

Publication Publication Date Title
Sandroni et al. Postural tachycardia syndrome: clinical features and follow-up study
Vieira et al. Oral piercings: immediate and late complications
Santana et al. Clinical evaluation of single‐stage advanced versus rotated flaps in the treatment of gingival recessions
DE04702967T1 (de) Behandlung von benigner prostatahyperplasie
FR3075642B1 (fr) Extrait de fleurs de kapokier et compositions cosmetiques, pharmaceutiques ou dermatologiques le comprenant
BRPI0507895A (pt) composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório
FR3047177B1 (fr) Compositions cosmetiques, dermatologiques comprenant un extrait de vitex negundo enrichi en polyphenols
Power-Smith Beneficial sexual side-effects from fluoxetine
TW200511996A (en) The use of steroids to treat persons suffering from ocular disorders
WO2020071665A3 (fr) Composition pour étendre le télomère de cellule et procédé de préparation associé
RU2189808C1 (ru) Крем для кожи тела и лица
BE1027772B1 (fr) Composition de ginseng pour ameliorer l&#39;etat de la peau et son utilisation pour le traitement d&#39;une maladie dermatologique
FR3130555B3 (fr) Composition comprenant au moins un acide boswellique et/ou au moins un extrait végétal comprenant au moins un acide boswellique pour utilisation topique dans le traitement des maladies inflammatoires de la peau
FR3091161B1 (fr) Extrait de chlamydomonas acidophila, son procede de preparation et les compositions cosmetiques, et dermatologiques le comprenant
Flack et al. Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases
De Wilde et al. A double‐blind randomized placebo‐controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression
Henquet et al. Studies on the autonomic nervous system in borderline hypertension
KR20200069711A (ko) 두피 케어용 두피에센스
RU2577240C1 (ru) Способ лечения травматических поражений слизистой оболочки полости рта в процессе ортодонтического лечения
Tysnes Treatment of sialorrhea in amyotrophic lateral sclerosis
Sevbitov et al. The influence of adhesive creams on the period of adaptation to removable dentures
Bardet et al. Clinical effects of root instrumentation using conventional steel or non‐tooth substance removing plastic curettes during supportive periodontal therapy (SPT)
Volden Peripheral neuropathy: a side effect of sulphones
MX2024004684A (es) Composiciones variantes de proteina sialidasa recombinante que escinde el acido sialico 181 (das181).
Bodnar et al. Pathology of oral mucosa in the elderly patients–clinical-statistical study

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20210621